Awarded a partially refundable grant for research project: Bluespe
Tue, 31/07/2018 - 00:00
1 minAwarded a partially refundable grant for research project: Bluespe
Related
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has reached an agreement with a subsidiary of MSD (“MSD”) whereby ROVI acquires certain...
2 min
15/02/2019
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has announced the purchase of Falithrom®, which was owned by Hexal AG (“Hexal”), a company...
1 min
09/01/2019
Awarded a partially refundable grant for research project: Bluespe